‘Share­hold­ers de­serve bet­ter’: Mereo lays off em­ploy­ees, push­es back against lead stake­hold­er's shake­up pro­pos­als 

Mereo Bio­Phar­ma has faced a se­ries of board- and com­pa­ny-shift­ing re­quests from its main share­hold­er Rubric Cap­i­tal Man­age­ment in re­cent months, and the UK biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER